Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
life sciences
national blog main
acute myeloid leukemia
adverum biotechnologies
allergan
ambit biosciences
athena countouriotis
boston
boston blog main
boston top stories
brett zbar
bristol-myers squibb
clinical trials
cormorant asset management
crispr
cynthia collins
daiichi sankyo
drugs
editas medicine
gene editing
halozyme therapeutics
hbm healthcare investments
hbm partners
jean cui
katrine bosley
leber congenital amaurosis
lilly asia ventures
national top stories
nextech invest
orbimed advisors
peter li
pfizer
quizartinib
repotrectinib
robert adelman
san diego
san diego blog main
san diego top stories
san francisco blog main
What
ceo
2
×
million
2
×
allergan
athena
biotech
blessing
bosley
cancer
check
chief
clinical
countouriotis
crispr
cusp
depart
drug
editas
editing
experimental
financing
gene
gets
humans
katrine
medical
medicine
mezzanine
names
new
officer
old
partner
promoted
push
raised
regulatory
round
test
therapeutics
therapy
Language
Current search:
ceo
×
million
×
biotech
×
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
